calendar
29,027 catalysts · 9,524 approval · 5,000 device 510k · 4,728 grant · 2,984 8k filing · 2,000 device pma · 2,000 device recall
29,027 catalysts · 9,524 approval · 5,000 device 510k · 4,728 grant · 2,984 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: RISING. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: RISING. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: RISING. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: RISING. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: RISING. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: UCB INC. Form: SOLUTION. Route: ORAL
Sponsor: NOVIMMUNE S.A.. Form: INJECTABLE. Route: INJECTION
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: JANSSEN BIOTECH. Form: TABLET. Route: ORAL
Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION
Sponsor: BAYER HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: PFIZER. Form: TABLET. Route: ORAL
Sponsor: TEVA PHARMS USA. Form: FOR SOLUTION. Route: ORAL
Sponsor: CHARTWELL RX. Form: CAPSULE. Route: ORAL
Sponsor: SCIEGEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: NOVITIUM PHARMA. Form: TABLET. Route: ORAL
Sponsor: TAKEDA PHARMS USA. Form: TABLET. Route: ORAL
Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: DR REDDYS LABS SA. Form: TABLET. Route: ORAL
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: EXELIXIS INC. Form: TABLET. Route: ORAL
Sponsor: WES PHARMA INC. Form: TABLET. Route: SUBLINGUAL
Sponsor: ACTAVIS ELIZABETH. Form: CAPSULE. Route: ORAL
Sponsor: ACTAVIS ELIZABETH. Form: CAPSULE. Route: ORAL
Sponsor: EUGIA PHARMA. Form: TABLET. Route: ORAL
Sponsor: EUGIA PHARMA. Form: TABLET. Route: ORAL
Sponsor: CENTOCOR ORTHO BIOTECH INC. Form: INJECTABLE. Route: INJECTION
Sponsor: BAYER HLTHCARE. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INJECTION
Sponsor: JANSSEN PHARMS. Form: SPRAY. Route: NASAL
Sponsor: JANSSEN PRODS. Form: TABLET. Route: ORAL
Sponsor: EUGIA PHARMA. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: TEVA PHARMS USA. Form: FOR SOLUTION. Route: ORAL
Sponsor: ASTELLAS. Form: TABLET. Route: ORAL
Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION
Sponsor: NALPROPION. Form: TABLET, EXTENDED RELEASE. Route: ORAL